| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.58 | 0.0007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |